BridgeBio Pharma, Inc.
BBIO NASDAQHealthcare ★★★★★Latest Earnings Below forecast↓
Date
Aug 10, 2026
ET
EPS Est.
-0.58
EPS Actual
-0.78
Revenue Est.
$220.9M
Revenue Actual
$243.7M
Next Earnings Report
Date
Oct 28, 2026 · Wed
Time
After-market
Fiscal Period
FY2026 Q3
EPS Est.
-0.67
Revenue Est.
$267.3M
Company Overview
BridgeBio Pharma, Inc. (ticker BBIO) is listed on NASDAQ with a market cap of about $15.96B. Its next earnings report (FY2026 Q3) is expected on Oct 28, 2026 (ET), After-market, with consensus EPS of -0.67. In the last 15 reported quarters, EPS beat consensus estimates 4 times.
Actual EPS TrendRecently15Term · Feb 23, 2023 → Aug 10, 2026
Feb 23, 2023Range: -1.31 ~ -0.20Aug 10, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 10, 2026 | -- | -0.58 | Below forecast↓-0.78 | $220.9M | $243.7M |
| May 7, 2026 | -- | -0.68 | Below forecast↓-0.84 | $178.1M | $194.5M |
| Feb 24, 2026 | -- | -0.71 | Below forecast↓-1.00 | $146.8M | $154.2M |
| Oct 29, 2025 | -- | -0.88 | -0.95 | $148.2M | $120.7M |
| Aug 5, 2025 | -- | -0.83 | -0.95 | $108.1M | $110.6M |
| Apr 29, 2025 | -- | -1.00 | -0.88 | $68.4M | $116.6M |
| Feb 20, 2025 | -- | -1.09 | Below forecast↓-1.31 | $4M | $5.9M |
| Nov 12, 2024 | -- | -1.03 | Above forecast↑-0.86 | $67.3M | $2.7M |
| Aug 1, 2024 | -- | -1.09 | Above forecast↑-0.39 | $4M | $2.2M |
| May 2, 2024 | -- | -0.71 | Above forecast↑-0.20 | $7.3M | $211.1M |
| Feb 22, 2024 | -- | -0.95 | -0.96 | $6.2M | $1.7M |
| Nov 2, 2023 | -- | -0.86 | Below forecast↓-1.08 | $4.3M | $4.1M |
| Aug 3, 2023 | -- | -0.86 | -0.98 | $3M | $1.6M |
| May 4, 2023 | -- | -0.84 | -0.92 | $3.4M | $1.8M |
| Feb 23, 2023 | -- | -0.86 | -0.87 | $4.5M | $1.9M |
Original Filings (SEC)
8-K2026-08-17 ↗
10-Q2026-08-10 ↗
8-K2026-08-10 ↗
8-K2026-07-22 ↗
8-K2026-07-02 ↗
8-K2026-06-26 ↗
8-K2026-05-27 ↗
8-K2026-05-13 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
